218 related articles for article (PubMed ID: 23163959)
1. Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety.
Sil A; Tripathi SK; Chaudhuri A; Das NK; Hazra A; Bagchi C; Islam CN
J Dermatolog Treat; 2013 Dec; 24(6):466-72. PubMed ID: 23163959
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24-h period: a double-blind, randomized, cross-over, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
Takeo T; Kasugai C; Tanaka R; Ando T; Ogawa A; Akita Y; Watanabe D
J Dermatol; 2013 Dec; 40(12):987-92. PubMed ID: 24303975
[TBL] [Abstract][Full Text] [Related]
4. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
[TBL] [Abstract][Full Text] [Related]
5. Levocetirizine and rupatadine in chronic idiopathic urticaria.
Johnson M; Kwatra G; Badyal DK; Thomas EA
Int J Dermatol; 2015 Oct; 54(10):1199-204. PubMed ID: 25521304
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
Tanizaki H; Yamamoto Y; Nakamizo S; Otsuka A; Miyachi Y; Kabashima K
Pharmacology; 2015; 95(1-2):32-5. PubMed ID: 25592003
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
[TBL] [Abstract][Full Text] [Related]
8. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
9. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Kapp A; Pichler WJ
Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
[TBL] [Abstract][Full Text] [Related]
10. Double dose of cetirizine hydrochloride is effective for patients with urticaria resistant: a prospective, randomized, non-blinded, comparative clinical study and assessment of quality of life.
Okubo Y; Shigoka Y; Yamazaki M; Tsuboi R
J Dermatolog Treat; 2013 Apr; 24(2):153-60. PubMed ID: 21810005
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.
Garg G; Thami GP
J Dermatolog Treat; 2007; 18(1):23-4. PubMed ID: 17365263
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
Dakhale GN; Shinde AT; Mahatme MS; Hiware SK; Mishra DB; Mukhi JI; Salve AM
Int J Dermatol; 2014 May; 53(5):643-9. PubMed ID: 24320728
[TBL] [Abstract][Full Text] [Related]
13. Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.
Kamei H; Isaji A; Noda Y; Ishikawa K; Senzaki K; Yamada K; Sugiura K; Tomita Y; Nabeshima T
Arch Dermatol Res; 2012 May; 304(4):263-72. PubMed ID: 22130869
[TBL] [Abstract][Full Text] [Related]
14. An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose.
Sharma VK; Gupta V; Pathak M; Ramam M
J Dermatolog Treat; 2017 Sep; 28(6):539-543. PubMed ID: 27779432
[TBL] [Abstract][Full Text] [Related]
15. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
[TBL] [Abstract][Full Text] [Related]
17. Levocetirizine and Prednisone Are Not Superior to Levocetirizine Alone for the Treatment of Acute Urticaria: A Randomized Double-Blind Clinical Trial.
Barniol C; Dehours E; Mallet J; Houze-Cerfon CH; Lauque D; Charpentier S
Ann Emerg Med; 2018 Jan; 71(1):125-131.e1. PubMed ID: 28476259
[TBL] [Abstract][Full Text] [Related]
18. Levocetirizine for chronic idiopathic urticaria: a review.
Ducharme EE; Weinberg JM
J Drugs Dermatol; 2009 Mar; 8(3):243-7. PubMed ID: 19271371
[TBL] [Abstract][Full Text] [Related]
19. An open-label, multicentre study of levocetirizine for the treatment of allergic rhinitis and urticaria in Taiwanese patients.
Fang SY; Perng DW; Lee JY; Lin DY; Huangs CY
Chin J Physiol; 2010 Aug; 53(4):199-207. PubMed ID: 21793329
[TBL] [Abstract][Full Text] [Related]
20. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
